Dr. Nagaraju Choragudi, MD

Dr. Choragudi practices at AnMed Medical Center in Anderson, South Carolina, part of AnMed.

Dr. Choragudi's NPI, 1467490839, was assigned on June 4, 2006. Dr. Choragudi holds Georgia license 77338.

Dr. Choragudi's primary practice is AnMed Medical Center, at 800 N Fant St, Anderson, SC 29621 in Anderson County. The practice phone is (864) 512-2830.

Dr. Choragudi's primary practice is AnMed Medical Center in Anderson, South Carolina, part of AnMed. Dr. Choragudi is also affiliated with Northeast Georgia Medical Center Gainesville. The medical group on file is 24 On Physicians, PC. Dmand AI also links Dr. Choragudi to 2 more hospitals and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choragudi practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Choragudi's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Choragudi's licenses on file in 2 states: Georgia and New York.

CMS data shows 1,175 Medicare services from Dr. Choragudi across 4 procedure codes in 2024, for 448 Medicare patients. Medicare paid $81,353 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 448 Medicare patients who saw Dr. Choragudi in 2024. The largest group is 75 to 84, with 172 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Choragudi's median patient age at 73, with 58% women.

In 2024, Dr. Choragudi wrote 1,350 Medicare Part D claims for 383 patients. 90% of them were for generic drugs. CMS names the drug for 993 of them, across 35 drugs with 11 or more claims each, at $25,265 in total drug cost. In 2023, CMS named 731 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Choragudi for performance year 2024, reported as part of a group. Dr. Choragudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Dr. Choragudi from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $141.